Report of Foreign Issuer (6-k)
October 02 2017 - 10:01AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE
13A-16
OR
15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
September 2017
Commission File Number
1-15182
DR. REDDYS LABORATORIES LIMITED
(Translation of registrants name into English)
8-2-337,
Road No. 3, Banjara Hills
Hyderabad,
Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of
Form 20-F
or
Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting the
Form 6-K
in paper as permitted by
Regulation S-T
Rule 101(b)(1): ☐
Note:
Regulation S-T
Rule 101(b)(1) only permits the submission in paper of a
Form 6-K
if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if
the registrant is submitting the
Form 6-K
in paper as permitted by
Regulation S-T
Rule 101(b)(7): ☐
Note:
Regulation S-T
Rule 101(b)(7) only permits the submission in paper of a
Form 6-K
if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrants home country), or under the rules of the home country exchange on which the registrants securities are traded, as long as the report or other document is not a press release, is
not required to be and has not been distributed to the registrants security holders, and, if discussing a material event, has already been the subject of a
Form 6-K
submission or other Commission
filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the
information to the Commission pursuant to Rule
12g3-2(b)
under the Securities Exchange Act of 1934.
Yes ☐ No ☒
If Yes is marked, indicate below the file number assigned to registrant in connection with
Rule 12g3-2(b):
82- .
EXHIBITS
|
|
|
Exhibit Number
|
|
Description of Exhibits
|
|
|
99.1
|
|
Press Release Dr. Reddys Laboratories announces the launch of Sevelamer Carbonate Tablets in the U.S. Market, dated September 29, 2017.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DR. REDDYS LABORATORIES LIMITED
|
|
|
|
|
|
|
(Registrant)
|
|
|
|
|
|
Date:
|
|
October 2, 2017
|
|
|
|
By:
|
|
/s/ Sandeep Poddar
|
|
|
|
|
|
|
|
|
Name: Sandeep Poddar
|
|
|
|
|
|
|
|
|
Title: Company Secretary
|
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dr Reddys Laboratories (NYSE:RDY)
Historical Stock Chart
From Sep 2023 to Sep 2024